Safety, Tolerability and Performance Profile of the Colospan Device CG-100 in Patients Undergoing Colorectal Surgery

Inclusion Criteria: * The patient is scheduled to undergo an elective colorectal surgery (open or laparoscopic) which will require the creation of an anastomosis, maximally 20 cm proximal from the anal verge * The patient is willing to comply with protocol-specified follow-up evaluations * The patient signed Informed Consent Exclusion Criteria: * Pregnant or nursing female subjects * Patient surgical treatment is acute (not elective) * Patient has infections at the time of intervention * Major surgical or interventional procedures within 30 days prior to this study or planned surgical or interventional procedures within 30 days of entry into this study * Patients with ASA (American Society of Anesthesiologists) classification \> 3 * diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel perforation, local or systemic infection, ischemic bowel, carcinomatosis or extensively spread inflammatory bowel disease * Patient is participating in another clinical trial within 30 days of screening * Patient has been taking regular steroid medication in the last 6 months * Contraindications to general anesthesia * Patient has preexisting sphincter problems or evidence of extensive local disease in the pelvis * Internal diameter lumen of the colon is smaller than 25 mm or larger than 34 mm * Blood loss (\> 500 cc) * Leak test failure during surgery * Any condition or surgical incidence where the device deployment can jeopardize the patient's safety or interferes with study outcome per the discretion of the investigator